146 related articles for article (PubMed ID: 16391802)
1. Identification of a novel SEREX antigen, SLC2A1/GLUT1, in esophageal squamous cell carcinoma.
Kuboshima M; Shimada H; Liu TL; Nakashima K; Nomura F; Takiguchi M; Hiwasa T; Ochiai T
Int J Oncol; 2006 Feb; 28(2):463-8. PubMed ID: 16391802
[TBL] [Abstract][Full Text] [Related]
2. Serum anti-myomegalin antibodies in patients with esophageal squamous cell carcinoma.
Shimada H; Kuboshima M; Shiratori T; Nabeya Y; Takeuchi A; Takagi H; Nomura F; Takiguchi M; Ochiai T; Hiwasa T
Int J Oncol; 2007 Jan; 30(1):97-103. PubMed ID: 17143517
[TBL] [Abstract][Full Text] [Related]
3. Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma.
Shimada H; Takeda A; Arima M; Okazumi S; Matsubara H; Nabeya Y; Funami Y; Hayashi H; Gunji Y; Suzuki T; Kobayashi S; Ochiai T
Cancer; 2000 Oct; 89(8):1677-83. PubMed ID: 11042560
[TBL] [Abstract][Full Text] [Related]
4. Increased serum midkine concentration as a possible tumor marker in patients with superficial esophageal cancer.
Shimada H; Nabeya Y; Okazumi S; Matsubara H; Kadomatsu K; Muramatsu T; Ikematsu S; Sakuma S; Ochiai T
Oncol Rep; 2003; 10(2):411-4. PubMed ID: 12579281
[TBL] [Abstract][Full Text] [Related]
5. Serological identification of tumor antigens of esophageal squamous cell carcinoma.
Shimada H; Nakashima K; Ochiai T; Nabeya Y; Takiguchi M; Nomura F; Hiwasa T
Int J Oncol; 2005 Jan; 26(1):77-86. PubMed ID: 15586227
[TBL] [Abstract][Full Text] [Related]
6. High serum soluble E-selectin levels are associated with postoperative haematogenic recurrence in esophageal squamous cell carcinoma patients.
Shimada Y; Maeda M; Watanabe G; Imamura M
Oncol Rep; 2003; 10(4):991-5. PubMed ID: 12792758
[TBL] [Abstract][Full Text] [Related]
7. Detection of anti-CUEC-23 antibodies in serum of patients with esophageal squamous cell carcinoma: a possible new serum marker for esophageal cancer.
Shimada H; Kagaya A; Shiratori T; Nomura F; Takiguchi M; Matsubara H; Hiwasa T
J Gastroenterol; 2009; 44(7):691-6. PubMed ID: 19407926
[TBL] [Abstract][Full Text] [Related]
8. Elevation of preoperative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma.
Shimada H; Nabeya Y; Okazumi S; Matsubara H; Shiratori T; Aoki T; Sugaya M; Miyazawa Y; Hayashi H; Miyazaki S; Ochiai T
J Surg Oncol; 2003 Aug; 83(4):248-52. PubMed ID: 12884238
[TBL] [Abstract][Full Text] [Related]
9. Clinical usefulness of CYFRA 21-1 for esophageal squamous cell carcinoma in radiation therapy.
Wakatsuki M; Suzuki Y; Nakamoto S; Ohno T; Ishikawa H; Kiyohara H; Kiyozuka M; Shirai K; Nakayama Y; Nakano T
J Gastroenterol Hepatol; 2007 May; 22(5):715-9. PubMed ID: 17444861
[TBL] [Abstract][Full Text] [Related]
10. [Human esophageal carcinoma antigens screened by serologic analysis of recombinant cDNA expression libraries (SEREX)].
Yu L; Hu H; Ran YL; Peng LP; Li JW; Yang ZH
Ai Zheng; 2007 Jan; 26(1):100-5. PubMed ID: 17222377
[TBL] [Abstract][Full Text] [Related]
11. Presence of serum tripartite motif-containing 21 antibodies in patients with esophageal squamous cell carcinoma.
Kuboshima M; Shimada H; Liu TL; Nomura F; Takiguchi M; Hiwasa T; Ochiai T
Cancer Sci; 2006 May; 97(5):380-6. PubMed ID: 16630135
[TBL] [Abstract][Full Text] [Related]
12. Polymorphonuclear leukocytes (PMN) activity in peripheral blood in patients with esophageal carcinoma.
Jabłońska E; Pietruska Z; Furman M; Kozłowski M
Arch Immunol Ther Exp (Warsz); 1994; 42(5-6):393-7. PubMed ID: 8572898
[TBL] [Abstract][Full Text] [Related]
13. Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced esophageal squamous cell carcinoma.
Dong J; Zeng BH; Xu LH; Wang JY; Li MZ; Zeng MS; Liu WL
J Transl Med; 2010 Sep; 8():81. PubMed ID: 20813067
[TBL] [Abstract][Full Text] [Related]
14. The diagnostic value of the measurement of matrix metalloproteinase 9 (MMP-9), squamous cell cancer antigen (SCC) and carcinoembryonic antigen (CEA) in the sera of esophageal cancer patients.
Mroczko B; Kozłowski M; Groblewska M; Łukaszewicz M; Nikliński J; Jelski W; Laudański J; Chyczewski L; Szmitkowski M
Clin Chim Acta; 2008 Mar; 389(1-2):61-6. PubMed ID: 18155162
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic application of detecting AgNOR in peripheral blood T lymphocyte in patients with esophageal carcinoma].
Wang JY; Rong TH; Liang YR; Long H; Chen QL; Ma GW
Ai Zheng; 2004 May; 23(5):577-80. PubMed ID: 15142458
[TBL] [Abstract][Full Text] [Related]
16. [Squamous cell carcinoma associated antigen levels in monitoring the response to surgical treatment for patients with esophageal carcinoma].
Zeng L
Zhonghua Yi Xue Za Zhi; 1993 Aug; 73(8):469-70, 510. PubMed ID: 8111645
[TBL] [Abstract][Full Text] [Related]
17. Expression and prognostic value of MG7-Ag in patients with surgically resectable esophageal squamous cell carcinoma.
Zhao Y; Jiang Y; Wang R; Zheng X; Wang X; Jin B; Lu Y; Qiao T; Hong L; Fan D
Ann Surg Oncol; 2007 Sep; 14(9):2621-7. PubMed ID: 17570016
[TBL] [Abstract][Full Text] [Related]
18. Soluble interleukin-2 receptor in serum of patients with esophageal carcinoma.
Jabłońska E; Kozłowski M; Pietruska Z; Furman M
Neoplasma; 1994; 41(6):315-8. PubMed ID: 7870214
[TBL] [Abstract][Full Text] [Related]
19. Identification of Makorin 1 as a novel SEREX antigen of esophageal squamous cell carcinoma.
Shimada H; Shiratori T; Yasuraoka M; Kagaya A; Kuboshima M; Nomura F; Takiguchi M; Ochiai T; Matsubara H; Hiwasa T
BMC Cancer; 2009 Jul; 9():232. PubMed ID: 19604354
[TBL] [Abstract][Full Text] [Related]
20. Titration of serum p53 antibodies in 1,085 patients with various types of malignant tumors: a multiinstitutional analysis by the Japan p53 Antibody Research Group.
Shimada H; Ochiai T; Nomura F;
Cancer; 2003 Feb; 97(3):682-9. PubMed ID: 12548611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]